Breaking News, Collaborations & Alliances

GreenLight Biosciences & Samsung Biologics Achieve mRNA Synthesis Reaction

Complete first commercial-scale engineering run for mRNA Covid-19 vaccine.

Author Image

By: Charlie Sternberg

Associate Editor

GreenLight Biosciences, a biotechnology company, and Samsung Biologics, a global CDMO providing fully integrated end-to-end contract development and manufacturing services, have completed the first commercial-scale engineering run for the companies’ mRNA production partnership.   Since the announcement of the strategic partnership between GreenLight Biosciences and Samsung Biologics in late 2021, technology transfer and scale-up from the lab bench to Samsung’s commercial facility w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters